CatamaranBio
@CatamaranBio
Cell Therapy Company developing allogeneic, off-the-shelf products for patients with high unmet medical need
You might like
Reflecting on the wonderful time we had volunteering at @ufiboston last week. It feels good to give back to our local community! #LifeScienceCares #NetworkofGood
We are proud to showcase our progress at SITC’s annual meeting this November. Poster #1001 “CAT-248 demonstrates in vivo expansion, tumor infiltration, and durable regression of multiple CD70-expressing xenograft tumors” will be presented at #SITC23 on Friday Nov 3rd!
Visit us at #ASGCT23 today to learn about the process modeling strategies we use to develop our CAT-179 and CAT-248 products. You can find us at Session H, board 753 from 12:00 – 4:00pm PT. #ASGCT2023 catamaranbio.com/wp-content/upl…
We are presenting preclinical efficacy data at #AACR23 for CAT-248 (CD70 CAR-NK) and CAT-179 (HER2 CAR-NK) on April 17th at 1:30pm ET. Posters will be available on @CatamaranBio's Publications and Presentations page on April 17th. catamaranbio.com/catamaran-news…
We have entered into a partnership with @CCRM_ca and #OmniaBio. This and other partnerships enhance our versatile TAILWIND® platform for the design and engineering of #CAR-NKs for #solidtumors. #celltherapy catamaranbio.com/catamaran-news…
We're looking forward to presenting preclinical efficacy data at #SITC2022 demonstrating the promise of our CAR-NK cell therapies, CAT-248 and CAT-179, for the treatment of solid tumors. catamaranbio.com/catamaran-news…
As we come to the official end of summer, we want to recognize our talented Interns from @ProjectOnramp . Britania Lewis, Dave Mansaray, and Kiin Mohamed – thank you for all your contributions! We look forward to partnering with #LifeScienceCaresBoston and @MassBio in 2023!
We're looking forward to seeing everyone at @CAR_TCell in Boston. Our team will be presenting on key emerging topics in cell therapy, including multiplex editing, assessing safety and efficacy, and improving patient access. car-tcr-summit.com #cartcr #Immunotherapy
Join us at the upcoming GEN Summit where Joe will be presenting critical analytical approaches to ensure safety and efficacy of novel CAR-NK cell therapies.
We’re excited to welcome two co-op students from Northeastern University. Through this program, students explore or refine potential career paths, make valuable connections, broaden perspectives, and acquire the skills and knowledge needed to succeed.
With our transposon-based NK cell modification technology we deliver large, complex genetic payloads and carry out multiplex engineering in a single step. This allows us to efficiently manufacture CAR-NK cell therapies with all the desired functional attributes.
Hope to see you at the upcoming HER2-Targeted Therapies Summit in Boston. Finola will be presenting on our CAR-NK cell therapy product candidate engineered to fight HER2+ tumors. her2-targeted-therapies.com
We're looking forward to the Symphony for Science, the Kendall Square Orchestra's annual benefit concert that will take place on May 23, 2022 at Symphony Hall in Boston.
We're looking forward to presenting new data at ASGCT today supporting novel engineered CAR-NK cell therapies for treating solid tumors. #ASGCT22 catamaranbio.com/catamaran-news…
We’re focused on solving the challenges presented by solid tumors and rapidly advancing CAT-179 and CAT-248 toward the clinic. #ChartingtheNKcourse catamaranbio.com/pipeline-progr…
Congratulations to the participants of the Massachusetts Science and Engineering Fair! We are proud to be part of your STEM journey and were excited to volunteer as judges in partnership with MSEF. The future of STEM shines brightly thanks to you.
We're presenting preclinical data at #ASGCT22 demonstrating CAR NK cell therapy design strategies to overcome the immunosuppressive effects of the solid tumor microenvironment. catamaranbio.com/catamaran-news…
Excited to have Cherry join the Catamaran team as Chief Medical Officer. catamaranbio.com/catamaran-news…
United States Trends
- 1. Rickey 2,254 posts
- 2. Big Balls 20.7K posts
- 3. Waddle 3,229 posts
- 4. Westbrook 16.1K posts
- 5. Kings 156K posts
- 6. Maybe in California N/A
- 7. #TrumpsShutdownDragsOn 4,925 posts
- 8. Argentina 527K posts
- 9. Olave 2,825 posts
- 10. Meyers 2,334 posts
- 11. Voting Rights Act 23.3K posts
- 12. Hayley 5,280 posts
- 13. Gold Glove 7,979 posts
- 14. Justice Jackson 15.6K posts
- 15. Veo 3.1 5,205 posts
- 16. Kate McKinnon 1,073 posts
- 17. Josh Simmons N/A
- 18. annabeth 2,189 posts
- 19. Capitol Police 24.8K posts
- 20. Eggs 29.1K posts
You might like
-
ArsenalBio
@ArsenalBio -
Ensoma
@EnsomaBio -
Dyne Therapeutics
@Dyne_tx -
Remix Therapeutics
@RemixThera -
HotSpot Therapeutics
@hotspotthera -
Caribou Biosciences
@CaribouBio -
Korro Bio
@KorroBio -
QIAGEN
@QIAGEN -
GRAIL
@GrailBio -
10x Genomics
@10xGenomics -
Q32 Bio Inc.
@Q32Bio -
Scholar Rock
@ScholarRock -
Vipin Suri
@VipinSuri4
Something went wrong.
Something went wrong.